text:
US Healthcare Providers
SPRAVATO® REMS
Is Becoming a REMS-certified SPRAVATO® Treatment Center Right for Your Practice?
What Is SPRAVATO®?
How My Practice Became a REMS-certified SPRAVATO® Treatment Center
What to Know About Becoming a REMS-Certified SPRAVATO® Treatment Center
Understanding How to Enroll
Complying With Controlled Substance Requirements
Considerations for SPRAVATO® Treatment
Understanding the Access and Reimbursement Process
Certify & Establish
Step 2: Acquisition
Step 3: Space
Treating Patients
Treat, Monitor, and Assess Patients
Supply and Storage of Product
Manage Used and Unused Product
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO®.
Prepare Patients for SPRAVATO® Treatment
Before starting patients on SPRAVATO®, you must provide a thorough consultation to discuss the potential benefits, risks and side effects, and process of SPRAVATO® treatment. This includes going over the patient's health history, explaining the reason for the observation period (checking blood pressure levels, sedation, and dissociation), reviewing the Boxed WARNINGS, and discussing the process and determination for release.1
Patients will need to know ahead of time that1:
they should avoid food for 2 hours and no liquids for 30 minutes prior to their visit
each appointment will last at least 2 hours, including monitoring
they will self-administer SPRAVATO®; a healthcare provider will show them how to use the nasal spray device
they will not be permitted to drive themselves home, so they must arrange transportation after every treatment session
they cannot engage in potentially hazardous activities requiring complete mental alertness and motor coordination, such as driving a motor vehicle or operating machinery, until the next day after a restful sleep
they will still be able to reach out to their referring HCP with any questions or to address concerns
Stay up to date with your patients' treatment. Get started using the Patient Treatment Progress form.
Patients must also be informed that SPRAVATO® treatment requires a series of frequent appointments.
For patients with treatment-resistant depression (TRD), these appointments will take place on a twice-weekly schedule for the first 4 weeks (the induction phase). Evidence of therapeutic benefit should be evaluated at the end of the induction phase to determine the need for continued treatment. If treatment continues, appointments will be once weekly for weeks 5 to 8, then once every week or 2 weeks thereafter.*1
For depressive symptoms in adult patients with major depressive disorder (MDD) with acute suicidal ideation or behavior, these appointments will take place twice weekly for 4 weeks. After 4 weeks of treatment with SPRAVATO®, evidence of therapeutic benefit should be evaluated to determine need for continued treatment.*
It's a good idea to set up these appointments at the outset to help ensure the proper timing is followed.
Patient REMS enrollment will differ in an inpatient vs. outpatient setting. In an outpatient setting, once your patient has agreed to start SPRAVATO® treatment, you will need to enroll him or her in the program by submitting a SPRAVATO® REMS Patient Enrollment Form. Then set up an intake appointment to get started.
REMS=Risk Evaluation and Mitigation Strategy.
* Treatment beyond 4 weeks has not been systematically evaluated.
LEARN MORE ABOUT THE SPRAVATO® REMS CERTIFICATION PROCESS ON THE REMS WEBSITE.
Before starting a patient on SPRAVATO®, you will need to investigate his or her insurance benefits and obtain prior authorization, if needed.
Once a prescribing decision has been made can help navigate access and affordability processes efficiently so you can focus on your patients
SPRAVATO withMe Case Managers provide you with educational support to help your patients start and stay on track.
SPRAVATO withMe SAVINGS PROGRAM
Eligible patients with commercial insurance pay as little as $10 per treatment for their SPRAVATO® medication. There are quantity limits and savings limits each year. Program does not cover the cost of treatment observation. Patients may participate without sharing their income information. See program requirements
SPRAVATO withMe is limited to education for patients about SPRAVATO®, its administration, and/or their disease, and is not intended to provide medical advice, replace a treatment plan from the patient's doctor or nurse, or provide case management services.
Learn more about how SPRAVATO withMe can help your patients at www.spravatohcp.com/spravato-with-me
Treat, Monitor and Assess Patients
TREAT PATIENTS WITH SPRAVATO®
AND FOLLOW UP
Reach out to the referring HCP before the first SPRAVATO® treatment session.
Once the patient has begun their treatment, keep an open line of communication with the referring HCP about their progress.
Remember to remind patients that they should not have food for 2 hours or liquids for 30 minutes prior to their visit. After a patient self-administers the SPRAVATO® dose under the supervision of a healthcare provider, he or she must then be monitored for a minimum of 2 hours, followed by an assessment to determine whether the patient is clinically stable and ready to leave the healthcare setting. Staff must also ensure that patients have someone to take them home as they cannot drive themselves.1
REVIEW THE RECOMMENDED DOSING AS NEEDED
Any time you want to review dosing for SPRAVATO® – either for patients with TRD or for depressive symptoms in adult patients with MDD with acute suicidal ideation or behavior – visit the SPRAVATO® website for US healthcare providers by clicking here.
SUBMIT THE APPROPRIATE FORMS FOR REIMBURSEMENT
In order to avoid delays in being reimbursed for the SPRAVATO® treatment, you should submit the appropriate forms as soon as possible. It may also be useful to click here to review the Access & Reimbursement Guide.
• If you are using a specialty pharmacy, you need only submit a claim for healthcare provider services
• If you are using the Buy-and-Bill process, you will need to submit a claim for both the medication and healthcare provider services
This is the point where you should also start planning for the next appointment.
SPRAVATO® is available in the following presentations:
56-mg dose kit: Unit-dose carton containing two 28-mg nasal spray devices (56-mg total dose) (NDC 50458-028-02)
84-mg dose kit: Unit-dose carton containing three 28-mg nasal spray devices (84-mg total dose) (NDC 50458-028-03)
Within each kit, each 28-mg device is individually packaged in a sealed blister (NDC 50458-028-00).
Once SPRAVATO® is delivered for a named-patient or is obtained for a healthcare setting's bulk supply, it must be kept in a secure place per state and federal regulations
Store at 20° to 25°C (68° to 77°F); excursions permitted from 15° to 30°C (59° to 86°F)
Product dispensed for a specific, named-patient must be administered within 14 days after receipt by the healthcare setting
After 14 days, unused named-patient products must be appropriately disposed of as per state and federal regulations and may not be returned to the general inventory of the healthcare setting or pharmacy
SPRAVATO® nasal spray devices must be handled with adequate security, accountability, and proper disposal, per facility procedure for a Schedule III drug product, and per applicable federal, state, and local regulations.
PLEASE REFER TO THE FULL PRESCRIBING INFORMATION AND INSTRUCTIONS FOR USE FOR MORE INFORMATION.
USED DEVICES
Once the SPRAVATO® device has been used by the patient, it should be disposed of as medical waste according to local, state, and federal regulations for controlled substances.
USED DEVICES Once the SPRAVATO® device has been used by the patient, it should be disposed of as medical waste according to local, state, and federal regulations for controlled substances.
UNUSED DEVICES
SPRAVATO® Disposal Program
Janssen has partnered with the SPRAVATO® Disposal Program, a reverse distribution company to support the safe return and destruction of partially used or unused dispensed patient-labeled product at no cost to the healthcare provider
WHEN TO USE IT?
If you have partially used devices — meaning the patient received one spray and then either the patient or the healthcare provider decided not to continue with treatment
If a pharmacy dispensed patient-labeled product to your healthcare setting and the patient was not treated with SPRAVATO® within 14 days of receipt
You can utilize the SPRAVATO® Disposal Program by calling 888-912-7348
When you call the SPRAVATO® Disposal Program, they will capture your name, practice name, address, DEA#, reason for disposal, # of units, NDC and description, lot #, and expiration date and send you a pre-populated packing slip (shipping label)
Package the device and send via UPS Ground Transportation using the packing slip provided by the SPRAVATO® Disposal Program
PARTIALLY USED DEVICES
If the patient received 1 spray and then either the patient or the healthcare provider decided not to continue with treatment, then the partially used product must be disposed of.
Turn to the SPRAVATO® Disposal Program to dispose of unused or partially used devices if your healthcare setting is not equipped to do so. Simply call 888-912-7348.
PARTIALLY USED DEVICES If the patient received 1 spray and then either the patient or the healthcare provider decided not to continue with treatment, then the partially used product must be disposed of.
EXPIRED PRODUCT
If the product is past the expiration date printed on the box and blister pack, then coordinate with the pharmacy that sent you the expired product to exchange it for new product.
If you purchased the product from a distributor or wholesaler, you can learn about the returns process and eligibility criteria by calling INMAR® at 800-967-5952, or click here to review Janssen's Returns Policy.
EXPIRED PRODUCT If the product is past the expiration date printed on the box and blister pack, then coordinate with the pharmacy that sent you the expired product to exchange it for new product.
HANDLING DEVICE MALFUNCTIONS
If the device has prematurely expelled medication — or won't expel medication — then a healthcare provider should call Janssen Medical Information at 800-JANSSEN to report a product quality complaint.
HANDLING DEVICE MALFUNCTIONS If the device has prematurely expelled medication — or won't expel medication — then a healthcare provider should call Janssen Medical Information at 800-JANSSEN to report a product quality complaint.
The Medical Information team will assist in taking complaint submission. Your staff must then determine how to obtain more product to prevent the patient from missing doses (if possible), and follow the process for returning the device.
1. SPRAVATO® [Prescribing Information].
Titusville, NJ: Janssen Pharmaceuticals, Inc. July 2020.
Learn about education and resources
Need a SPRAVATO® REMS-certified pharmacy?
Call 855-382-6022 or visit SPRAVATOrems.com
To find out more about SPRAVATO withMe or to enroll your patients, give us a call at 1- 844-4S-WITHME (1-844-479-4846), Monday through Friday, from 8:00 AM to 8:00 PM ET.
SPRAVATO® (esketamine) CIII Nasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of:
Treatment-resistant depression (TRD) in adults.
Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.
Limitations of Use:
The effectiveness of SPRAVATO® in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. Use of SPRAVATO® does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO®.
SPRAVATO® is not approved as an anesthetic agent. The safety and effectiveness of SPRAVATO® as an anesthetic agent have not been established.
WARNING: SEDATION, DISSOCIATION; ABUSE AND MISUSE; and SUICIDAL THOUGHTS AND BEHAVIORS
See full prescribing information for complete boxed warning
Risk for sedation and dissociation after administration. Monitor patients for at least two hours after administration (5.1, 5.2).
Potential for abuse and misuse. Consider the risks and benefits of using SPRAVATO® prior to use in patients at higher risk of abuse. Monitor for signs and symptoms of abuse and misuse (5.3).
SPRAVATO® is only available through a restricted program called the SPRAVATO® REMS (5.4).
Increased risk of suicidal thoughts and behaviors in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. SPRAVATO® is not approved for use in pediatric patients (5.5).
SPRAVATO® is contraindicated in patients with:
Aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial and peripheral arterial vessels) or arteriovenous malformation.
History of intracerebral hemorrhage.
Hypersensitivity to esketamine, ketamine, or any of the excipients.
Sedation: In clinical trials, 48% to 61% of SPRAVATO®-treated patients developed sedation and 0.3% to 0.4% of SPRAVATO®-treated patients experienced loss of consciousness.
Because of the possibility of delayed or prolonged sedation, patients must be monitored by a healthcare provider for at least 2 hours at each treatment session, followed by an assessment to determine when the patient is considered clinically stable and ready to leave the healthcare setting.
Closely monitor for sedation with concomitant use of SPRAVATO® with CNS depressants (e.g., benzodiazepines, opioids, alcohol).
Dissociation: The most common psychological effects of SPRAVATO® were dissociative or perceptual changes (including distortion of time, space and illusions), derealization and depersonalization (61% to 84% of SPRAVATO®-treated patients developed dissociative or perceptual changes). Given its potential to induce dissociative effects, carefully assess patients with psychosis before administering SPRAVATO®; treatment should be initiated only if the benefit outweighs the risk.
Because of the risks of dissociation, patients must be monitored by a healthcare provider for at least 2 hours at each treatment session, followed by an assessment to determine when the patient is considered clinically stable and ready to leave the healthcare setting.
Abuse and Misuse: SPRAVATO® contains esketamine, a Schedule III controlled substance (CIII), and may be subject to abuse and diversion. Assess each patient's risk for abuse or misuse prior to prescribing and monitor all patients for the development of these behaviors or conditions, including drug-seeking behavior, while on therapy. Individuals with a history of drug abuse or dependence are at greater risk; therefore, use careful consideration prior to treatment of individuals with a history of substance use disorder and monitor for signs of abuse or dependence.
SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS): SPRAVATO® is available only through a restricted program called the SPRAVATO® REMS because of the risks of serious adverse outcomes from sedation, dissociation, and abuse and misuse.
Important requirements of the SPRAVATO® REMS include the following:
Healthcare settings must be certified in the program and ensure that SPRAVATO® is:
Only dispensed and administered in healthcare settings.
Patients treated in outpatient settings (e.g., medical offices and clinics) must be enrolled in the program.
Administered by patients under the direct observation of a healthcare provider and that patients are monitored by a healthcare provider for at least 2 hours after administration of SPRAVATO®.
Pharmacies must be certified in the REMS and must only dispense SPRAVATO® to healthcare settings that are certified in the program.
Further information, including a list of certified pharmacies, is available at www.SPRAVATOrems.com or 1-855-382-6022.
Suicidal Thoughts and Behaviors in Adolescents and Young Adults: In pooled analyses of placebo-controlled trials of antidepressant drugs (SSRIs and other antidepressant classes) that included adult and pediatric patients, the incidence of suicidal thoughts and behaviors in patients age 24 years and younger was greater than in placebo-treated patients. SPRAVATO® is not approved in pediatric (<18 years of age) patients.
There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied.
Monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors, especially during the initial few months of drug therapy and at times of dosage changes. Counsel family members or caregivers of patients to monitor for changes in behavior and to alert the healthcare provider. Consider changing the therapeutic regimen, including possibly discontinuing SPRAVATO® and/or the concomitant oral antidepressant, in patients whose depression is persistently worse, or who are experiencing emergent suicidal thoughts or behaviors.
Increase in Blood Pressure: SPRAVATO® causes increases in systolic and/or diastolic blood pressure (BP) at all recommended doses. Increases in BP peak approximately 40 minutes after SPRAVATO® administration and last approximately 4 hours.
Approximately 8% to 19% of SPRAVATO®-treated patients experienced an increase of more than 40 mmHg in systolic BP and/or 25 mmHg in diastolic BP in the first 1.5 hours after administration at least once during the first 4 weeks of treatment. A substantial increase in blood pressure could occur after any dose administered even if smaller blood pressure effects were observed with previous administrations. SPRAVATO® is contraindicated in patients for whom an increase in BP or intracranial pressure poses a serious risk (e.g., aneurysmal vascular disease, arteriovenous malformation, history of intracerebral hemorrhage). Before prescribing SPRAVATO®, patients with other cardiovascular and cerebrovascular conditions should be carefully assessed to determine whether the potential benefits of SPRAVATO® outweigh its risk.
Assess BP prior to administration of SPRAVATO®. In patients whose BP is elevated prior to SPRAVATO® administration (as a general guide: >140/90 mmHg), a decision to delay SPRAVATO® therapy should take into account the balance of benefit and risk in individual patients.
BP should be monitored for at least 2 hours after SPRAVATO® administration. Measure blood pressure around 40 minutes post-dose and subsequently as clinically warranted until values decline. If BP remains high, promptly seek assistance from practitioners experienced in BP management. Refer patients experiencing symptoms of a hypertensive crisis (e.g., chest pain, shortness of breath) or hypertensive encephalopathy (e.g., sudden severe headache, visual disturbances, seizures, diminished consciousness, or focal neurological deficits) immediately for emergency care.
Closely monitor blood pressure with concomitant use of SPRAVATO® with psychostimulants (e.g., amphetamines, methylphenidate, modafinil, armodafinil) or monoamine oxidase inhibitors (MAOIs).
In patients with a history of hypertensive encephalopathy, more intensive monitoring, including more frequent blood pressure and symptom assessment, is warranted because these patients are at increased risk for developing encephalopathy with even small increases in blood pressure.
Short-Term Cognitive Impairment: In a study in healthy volunteers, a single dose of SPRAVATO® caused cognitive performance decline 40 minutes post-dose. Compared to placebo-treated subjects, SPRAVATO®-treated subjects required a greater effort to complete the cognitive tests at 40 minutes post-dose. Cognitive performance and mental effort were comparable between SPRAVATO® and placebo at 2 hours post-dose. Sleepiness was comparable after 4 hours post-dose.
Long-Term Cognitive Impairment: Long-term cognitive and memory impairment have been reported with repeated ketamine misuse or abuse. No adverse effects of SPRAVATO® nasal spray on cognitive functioning were observed in a one-year open-label safety study; however, the long-term cognitive effects of SPRAVATO® have not been evaluated beyond one year.
Impaired Ability to Drive and Operate Machinery: Before SPRAVATO® administration, instruct patients not to engage in potentially hazardous activities requiring complete mental alertness and motor coordination, such as driving a motor vehicle or operating machinery, until the next day following a restful sleep. Patients will need to arrange transportation home following treatment with SPRAVATO®.
Ulcerative or Interstitial Cystitis: Cases of ulcerative or interstitial cystitis have been reported in individuals with long-term off-label use or misuse/abuse of ketamine. In clinical studies with SPRAVATO® nasal spray, there was a higher rate of lower urinary tract symptoms (pollakiuria, dysuria, micturition urgency, nocturia, and cystitis) in SPRAVATO®-treated patients than in placebo-treated patients. No cases of esketamine-related interstitial cystitis were observed in any of the studies, which involved treatment for up to a year.
Monitor for urinary tract and bladder symptoms during the course of treatment with SPRAVATO® and refer to an appropriate healthcare provider as clinically warranted.
PREGNANCY, EMBRYO-FETAL TOXICITY, AND LACTATION
SPRAVATO® is not recommended during pregnancy. SPRAVATO® may cause fetal harm when administered to pregnant women. Advise pregnant women of the potential risk to an infant exposed to SPRAVATO® in utero. Advise women of reproductive potential to consider pregnancy planning and prevention.
There are risks to the mother associated with untreated depression in pregnancy. If a woman becomes pregnant while being treated with SPRAVATO®, treatment with SPRAVATO® should be discontinued and the patient should be counseled about the potential risk to the fetus.
Pregnancy Exposure Registry: There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants, including SPRAVATO®, during pregnancy. Healthcare providers are encouraged to register patients by contacting the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/.
SPRAVATO® is present in human milk. Because of the potential for neurotoxicity, advise patients that breastfeeding is not recommended during treatment with SPRAVATO®.
SELECT USE IN SPECIFIC POPULATIONS
Geriatric Use: No overall differences in the safety profile were observed between patients 65 years of age and older and patients younger than 65 years of age. At the end of a 4-week, randomized, double-blind study, there was no statistically significant difference between groups on the primary efficacy endpoint.
Hepatic Impairment: SPRAVATO®-treated patients with moderate hepatic impairment may need to be monitored for adverse reactions for a longer period of time.
SPRAVATO® has not been studied in patients with severe hepatic impairment (Child-Pugh class C). Use in this population is not recommended.
The most common adverse reactions with SPRAVATO® plus oral antidepressant (incidence ≥5% and at least twice that of placebo nasal spray plus oral antidepressant) were:
TRD: dissociation, dizziness, nausea, sedation, vertigo, hypoesthesia, anxiety, lethargy, blood pressure increased, vomiting, and feeling drunk.
Treatment of depressive symptoms in adults with MDD with acute suicidal ideation or behavior: dissociation, dizziness, sedation, blood pressure increased, hypoesthesia, vomiting, euphoric mood, and vertigo.
cp-170362v2
Medical Information Center
SPRAVATO withMe
This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its contents. This site is intended for use by healthcare professionals of the United States and its territories. Janssen Pharmaceuticals, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and its territories.
Third party trademarks used herein are trademarks of their respective owners.
© Janssen Pharmaceuticals, Inc. 2022. All rights reserved.
Last Updated 10/2022 | cp-137909v5
You are leaving the SPRAVATO® (esketamine) CIII website
You are being directed to a third-party website:
[extlink:external-url]
This link is provided for your convenience. Please note that this third-party website is not controlled by Janssen Pharmaceuticals, Inc. or subject to our Privacy Policy.
Thank you for visiting our site. We hope your visit was informative.
Loading Common Footer...


A shocking documentary about a failed military coup in Spain was watched by over 5 million people on Sunday evening but not all was as it seemed.
Operacíon Palace was a massive hit with 5.2 million Spaniards tuning in to the documentary about the country's failed military coup in 1981.
Presented by the hugely popular journalist Jordi Évole, the film promised to reveal the secret 'truth' about one of the key moments in modern Spanish history.
On February 23rd 1981, 200 Guardia Civil officers led by Colonel Antonio Tejero stormed the Spanish Parliament hoping to re-establish military rule in the country.
Spain's fledgling democracy was just six years old, and struggling to assert itself after the death of long-term dictator Francisco Franco.
Footage of the attempted coup is as famous within Spain as that of the moon landing or the assassination of John F. Kennedy in Dallas.
It shows shots coup leader Tejero brandishing a pistol and firing shots at the ceiling when one politician attempts to tackle officers loyal to the colonel.
The coup ended after King Juan Carlos gave an iconic TV speech in which he urged Spaniards to keep their faith in democracy. By the following day, the political hostages were freed and the coup leaders surrendered to police.
The failed coup, often referred to as 23-F for the date on which it happened, came to represent the victory of democracy over fascism in Spain.
But Sunday night's heavily-hyped television documentary — aired on TV station LaSexta — claimed it would rewrite the history books.
In an Orson Wells-style programme, Operation Palace made the shocking assertion that the coup itself and the king's speech had been staged to boost the king's image.
This caused a storm of commentary on Twitter as people wrote about what they were seeing.
For a couple of hours, the hashtag #operacionpalace hit trending topic status within Spain and internationally.
And then came the big reveal: at the end of the show Évole told the massive audience the whole documentary was a fake. He explained it was based on the French mockumentary Dark Side of the Moon which argued the first moon landing was staged by the CIA.
"I know some of you will happy with what you have seen, while others will feel cheated and want to kill me" said the Catalan journalist in the wash-up to the show.
"At least we admitted that it (the documentary) was a lie and surely there were other times when you were lied to and nobody said so," he added.
The show itself has turned Spain into a nation of 'pro-Evolistas' and 'anti-Evolistas'. Some, like the tweet below are very clear in their praise.
Others, meanwhile have speculated what the fake documentary means for journalism.
"Like many of you I'm asking myself: "Does this type of experiment favour the credibility of the press? Worrying," wrote Twitter user Beatriz Corredor.
"I'm all for experiments and innovation but you can't play with people's fear as Operation Palace did," tweeted Rosa María Artal.
Others took a more pragmatic view.
"The main result of #operationpalace is that the event has created the biggest number of deleted tweets once people watched the end (of the show)," wrote Twitter user Pepe Oneto.


text:
Siasat.com/Entertainment/Bollywood/Priyanka Chopra gushes about her 'Paani' production team
Priyanka Chopra gushes about her 'Paani' production team
| Updated: 10th August 2019 1:40 pm IST
New Delhi: The 66th National Film Awards were announced on Friday and Priyanka Chopra is filled with praises for the team of her Marathi production 'Paani' which won the Best Feature Film on Environment Conservation award.
I'm so proud to have produced a special film like #Paani. Congratulations to the entire team at @purplepebblepictures @madhumalati @siddharthchopra89 for our second National Award. Big congratulations to @adinathkothare and the entire creative team for bringing this challenging and relevant film to its fruition. My sincere gratitude to the jury for recognising our hard work and awarding #Paani with the 'Best Feature Film on Environment Conservation'. It has given us further impetus to continue on the path of telling the stories we strongly believe in. #Paani was our humble attempt at using entertainment to bring focus to the seriousness of the water crisis, which is of grave concern the world over. We are so honoured that the film had an impact and that our efforts have been recognised.
A post shared by Priyanka Chopra Jonas (@priyankachopra) on Aug 9, 2019 at 12:19pm PDT
Dedicating a mushy post to the team and not forgetting the mention of her mother Madhu Chopra on Instagram, Priyanka wrote, "I'm so proud to have produced a special film like Paani. Congratulations to the entire team at Purple Pebble Pictures Madhu Chopra Siddharth Chopra for our second National Award."
She also congratulated the film's director Adinath Kothare for his efforts to bring out this "challenging" and "relevant" film.
"Big congratulations to Adinath Kothare and the entire creative team for bringing this challenging and relevant film to its fruition," she added.
The post continued to read words of thanks for the jury who selected the film for the award, "My sincere gratitude to the jury for recognizing our hard work and awarding Paani with the 'Best Feature Film on Environment Conservation'."
While the award did honour the people associated behind the idea and execution in the film, Priyanka shared that the film was their attempt to use media to the utmost and bring focus on the "seriousness of the water crisis".
Priyanka and the team also received a congratulatory note from the actor's husband and singer Nick Jonas.
"So proud of Priyanka Chopra and the entire Purple Pebble Pictures team for their national award for Paani congrats to everyone involved!" he tweeted.
The National Awards are the most prominent film award ceremony in the country. Established in 1954, it has administered, along with the International Film Festival of India and the Indian Panorama by the Indian government's Directorate of Film Festivals since 1973.
Marathi film National Film Awards Paani Priyanka Chopra
Get the news updates on WhatsApp & Telegram by subscribing to our channels. For all the latest Bollywood updates, download our app Android and iOS.

redpajama_set_name: RedPajamaCommonCrawl


text:
We use cookies to give you the best possible experience on our website. Sluiten
Newsletter Register
Final Event: NBC 2021 Ends With a Bang!
The Expedition Trips of the New Business Challenge 2021 has come to a successful end. Due to the restrictions imposed by the COVID- 19 pandemic, a new structure of the NBC was introduced, the first ever NBC Summer school and Expedition Trips to Ghana and the Netherlands. After an intense month of exploring the Netherlands and Ghana, working in intercultural teams and brainstorming on solutions to real business challenges, the NBC 2021 has come to a successful end.
During the Expedition Trips, participants worked together in mixed teams to develop the best solutions to the business cases of:
The Good Roll Africa – The Good Roll Africa was looking for innovative approaches to sell its sustainable toilet rolls to the Ghanaian market
Delphy BV – Delphy wanted to discover effective ways to understand the work culture and cooperate optimally with their partners abroad.
Ocean Green Beach Villas – Ocean Green sought to boost revenue generation in order to complete the first phase of its project by 2025.
Tropical Growers – Tropical Growers wanted to introduce and excite high schools in Ghana about the use of hydroponics in planting.
Jolinaiko Eco Tours – Jolinaiko was searching for revenue generating activities to be offered at their Clean and Green Hub whilst contributing to the green environment.
After each company visit, participants cast their votes for the most feasible and impactful concept to be presented during the final event which was held at the Residence of the Netherlands Ambassador to Ghana, all the teams prepared a poster to showcase their innovative ideas.
The Final Event began with a warm welcome by H.E. Jeroen Verheul, the Netherlands Ambassador to Ghana. He emphasized how delighted the Netherlands Embassy is to foster the relations between Ghana and the Netherlands through innovative young minds. He expressed his interest in the program and his desire to see these solutions implemented by the companies. Following on from that, Nana Newman, Co-founder of Tropical Growers, shared his thoughts on the NBC. He was appreciative of the solutions by the participants and was eager to apply them to the business challenge of Tropical Growers.
Cees Dekker, Project Manager for the NBC also expressed his thoughts about the NBC from the perspective organizer's perspective. NBC Participants, Esther Asamoah and Donné Wagemans also shared some highlights from their NBC experience, the indelible impact the NBC has had and key skills that gained and harnessed during the trips.
Afterwards, participants were presented certificates by H.E Jeroen Verheul and Tjalling Wiarda, General Manager at GNBCC. The event was well attended by GNBCC Members and Clients, Baba Osman Daney (Finance Director at the National Youth Authority) as well as NBC Alumni. Partcipants presenteted their solutions to all attendees and the evening closed with a networking session.
With a bang, the NBC 2021 Trip Ghana came to an end. A big thank you to everyone who made the NBC 2021 possible, especially the project coordinators Cees Dekker from SustainableMotion and Tracy Mensah from GNBCC . A bigger thank you for the coaches: Jemila Abdulai and Diwy Tomassen for their guidance and support during the New Business Challenge. A special thank you to Joana Chemel of the Ghana Design Network, for moderating the event. Kudos to the brilliant participants who made this NBC an unforgettable experience, and last but not least, The Netherlands Enterprise Agency (RvO) and The Netherlands Embassy in Accra for their unwavering support of the New Business Challenge.
One down, one more to go. The NBC 2022 is fast approaching. Don't be left behind keep an eye on our website and Facebook page.


In the second round of the last election on October 25, 2015, he became a Senator from North East under the banner of Verite political party with 39.42% votes.
In last April, when the links of some high profile Haitians were discovered in Panama scam, then as a Senator, Ronald Lareche said, a special commission would be created to investigate the spending and contracts under the administration of former President Michel Martelly's regime between 2011-2016.
Here is Senator Ronald Lareche in Mont Organise. He joined Haitian national Police (PNH) in 1995 and later became the Supervisor of Police in his hometown in Mont Organise. He was agent 2.
On Wednesday, July 20, 2016, the former vice president of the Senate, Ronald Larèche has been elected the president of the Senate replacing the current interim president Jocelerme Privert. Mr. Ronald Larèche (born on November 21, 1971 in Mont-Organizes), the former Senator of the North East, by profession is a lawyer and a member of the Parliamentary Group of the Renewal (GPR) Commissions and member of several high profile committees such as, Committee on Foreign Affairs, Worship and Haitians living abroad, Committee on Interior and Local government, Decentralization and Border Development. He is also a member of the Commission for Justice and Public Safety. Now, the new Bureau is thus composed of Ronald Larèche (President), I. Steven Benoit (vice president), Junior Jean Marie Solomon (First Secretary), Lucas François St-Vil (Second Secretary) and Fritz Carlos Lebon (Quaestor, in charge of public revenue and expenditure). Ronald Larèche has been active in politics since 1985.
Here is Congresswoman Frederica S. Wilson, representing one of the most ethnically and culturally diverse districts in the nation.
She was behind the introduction of many important bills such as, (a) innovative American Jobs Act of 2013 aiming to promote full employment and boosts workforce development opportunities; (b) the Student Loan Borrower Bill of Rights to relieve the overburdened student loan borrowers; and (c) the Youth Corp Act of 2013 to reconnect youth with education, the workforce and their communities. She has worked to defend Haitian women against gender-based violence, protection of foster children and introduced legislation to reduce homeowners' insurance premiums. With her mantra "Jobs, Jobs, Jobs," she organized one of the state's largest job fairs where over 100 local and national employers interacted with thousands of Floridians. In 2014, she arranged $1 million grant to help reduce crime in Miami-Dade County's highest crime area, the North Side District.
Wilson is famous for her large and colorful hats which she has a collection of over hundreds of different varieties. She has proposed to waive the rule prohibiting the wearing of hats on the floor of the House of Representatives, a rule in place since 1837.
Here is a picture of Congresswoman Frederica S. Wilson, member of the Education and Workforce Protections Subcommittee.
This Florida lawmaker, a member of the Democratic Party has earned a reputation as "Voice for the Voiceless." In 2012, she gained national attention for her high profile comments on racism, which was instigated by the killing of Trayvon Martin, a 17 year old African American from Miami Gardens, Florida, who was fatally shot by George Zimmerman, a neighborhood watch volunteer, in Sanford, Florida.
Frederica Smith Wilson (born as Frederica Patricia Smith on November 5, 1942) has been representing the Florida's 24th Congressional District since 2013. Her maternal grandparents were Bahamian. During her first two years in Congress, she had represented the 17th Congressional District in South Florida. She was an elementary school principal (Skyway Elementary School in Miami), school board member (Miami-Dade County School Board), state legislator (from 1999 to 2002), community leader and founder of the 5000 Role Models of Excellence Project with a main issue to bring down school dropout rates. She earned her B.A degree from Fisk University in 1963 and her M.A degree from the University of Miami in 1972.


text:
GNO, Inc. Commends Progress In Regional Resiliency
Biz New Orleans Site Staff,
NEW ORLEANS – Greater New Orleans, Inc. congratulates the U.S. Department of Housing and Urban Development (HUD's) National Disaster Resilience Competition (NDRC) award winners and applicants from the Greater New Orleans region. Via this federal grant completion, over $233 million were awarded to Southeast Louisiana to advance innovative resiliency projects.
With Orleans Parish receiving $141,260,569 and the State of Louisiana receiving $92,629,249, Louisiana collectively received one of the highest allocations in this process. Each application will further projects around community development, water management and adaptive planning.
As one of the top contenders for the $1 billion pot of NRDC funds, four Louisiana entities progressed through the two-phased application process. These four approved applicants included:
• State of Louisiana (whose application specifically included projects in Lafourche, Plaquemines, St. John the Baptist, and Terrebonne parishes)
• Orleans Parish
• Jefferson Parish
• St. Tammany Parish
While NDRC funds were only received by the State of Louisiana and the City of New Orleans, the application process catalyzed extraordinary momentum and advanced planning around resiliency initiatives in Jefferson and St. Tammany Parishes. GNO, Inc. especially commends the thorough consideration each of these parishes put towards their applications and looks forward to continuing to work with both Jefferson and St. Tammany Parishes on ongoing resiliency initiatives.
Moving forward, all NDRC applicants and other parishes across the region will coordinate via the New Orleans Regional Planning Commission's Resiliency Subcommittee. Additionally, St. Tammany and Jefferson Parishes are committed to advancing the following:
• Jefferson Parish: Will continue advancing innovative water management practices across the Parish. Specifically, the Metairie Bayou Park is providing a new water management pilot for the Parish. Additionally, the parking lot of the Yenni Building in Elmwood is undergoing a design process to incorporate water management elements.
• St. Tammany Parish: Will continue the implementation of a replicable, green infrastructure program that addresses environmental degradation, coastal land loss, storm water management, and water quality. Further, St. Tammany Parish Government is currently in the process of revising development standards to incorporate resilience, including climate change, coastal land loss, water quality, storm water management, sudden population increases, and the ordinary and extraordinary shocks and stressors to the community.
Additionally, all NDRC applicants locally and nationally will have an opportunity to continue learning more about innovative international, national and local resilience models at the upcoming RES/CON New Orleans conference which will highlight the NDRC process and projects.
"Resiliency doesn't end with a grant process: it is an ongoing paradigm shift across a number of spheres, including the private sector," said Michael Hecht, President and CEO of GNO, Inc. GNO, Inc. looks forward to continuing advancing resiliency in the region to not only create a more sustainable physical environment for business, but also to foster a new industry sector—Environmental Management—that is ready to profitably engage in these new challenges."
"In addition to the potential business and workforce opportunity these significant infrastructure investments will generate, GNO, Inc. is also excited to see a significant advancement of Greater New Orleans Urban Water Plan Principles and demonstration projects," said Robin Barnes, Executive Vice President and COO of GNO, Inc. "GNO, Inc. created the Plan for this very purpose: to catalyze new innovation and momentum in the water management sector."
Categories: Today's Business News
Artist, Activist and Volunteer Brian Sands Epitomizes What I Love About New Orleans


text:
The capital news from Ukraine
All news of this category
national finance
Coalition wants to write off tax debts of financial groups
Capital, Economy and finance department reporter
Rostyslav Shapravskiy
56666 5 December 2014, Friday, №201 (378)
Perhaps there is some outside chance that the tax burden for business entities will be alleviated
Photo: Konstantin Melnitskiy
The Verkhovna Rada offers fiscal authorities and business entities evading payment of taxes to conclude a peace treaty. MPs representing the coalition initiated a bill on a tax compromise. The document reads that 95% of all taxes, which companies optimized through shady schemes prior to April 1, 2014 and did not disclose them, will be written off, provided that the remaining 5% is paid. The matter is about profit taxes and the VAT. Within 90 days after adoption of the law, companies will be required to clarify the calculations of tax liabilities. Repentant companies are promised amnesty and a guarantee that the tax and law enforcement authorities will forget about their shady past. Those that have nothing to hide from the fiscal services are not pleased about the innovations and requesting not to hurry with the adoption of the law prior to its finalization.
Attempt #2
The law on tax compromise was supposed to be adopted a few months ago. In June, the previous convocation of the parliament voted for a similar document in the first reading, but it was not adopted in the second reading. For tax evaders the first version was less attractive, because it suggested a 15% payment of the tax debt and less than 30 days for voluntary payment. Earlier, the Ekonomichna Pravda newspaper, referring to its sources, wrote that the head of the Privat Group and Governor of the Dnipropetrovsk Oblast Ihor Kolomoiskiy insisted on the 5% rate. However, there were other "destitutes".
Experts say that many companies expressed their opinions during debate of provisions of the bill. Some companies managed to sell almost all their goods through tax evasion schemes, says Vice President of the Ukrainian Union of Industrialists and Entrepreneurs (UUIE) Yulia Drohovoz. "Now, such enterprises will have to pay additional taxes not only on their profits, but on their entire turnover. And 10% or 15% is a huge amount for them," said the expert. A higher rate of tax compromise would suit companies, which minimized their incomes or exceeded the tax credit for VAT. Moreover, Drohovoz explained that 5% and 95% proportions of a tax compromise were applied at one time in Italy. After disclosure of the real incomes of businesses, Italy had the best effect on the budget among all countries that have used such a tool.
It is therefore not surprising that the government supports the notion of a tax compromise, knowing that in the context of the current situation with non-fulfillment of the budget any compensators may prove to be helpful. If the parliament adopts the document later this year, then, according to Chair of the State Fiscal Service (SFS) Ihor Bilous, the budget will receive an additional UAH 2–3 bn in revenues. Moreover, the SFS predicts a failure in collection of profit taxes, which were previously collected in advance payments.
Those business entities that have no problems with tax bodies do not share the hopes of the Cabinet. "Companies that pay taxes honestly are concerned that when their suppliers or buyers start charging additional taxes and make corrections in declarations the tax authorities could go up the chain and demand them to make payments," explains Drohovoz.
Earlier, Energoatom made a similar statement, asking the authorities to define guarantees for honest taxpayers more clearly. "According to the algorithm, prescribed in the bill, the company is obligated to provide updated estimates for taxes in prior periods on the same terms with those which evaded taxes. The ultimate outcome is not difficult to guess: the endless faultfinding inspections of fiscal authorities can simply paralyze the company's financial and economic activities," said representatives of the press service of Energoatom.
There is a chance that the document on the tax compromise will be adopted by the end of the year, but only as part of the budget package of laws, said head of the parliamentary group Economic Development and one of the authors of the bill on the tax compromise Vitaliy Khomutynnyk. Drohovoz also confirmed the need to vote for this document in conjunction with other bills, because having received a tax compromise, though according to the previous fiscal base, business entities will again be forced to resort to tax evasion.
Verkhovna Rada, coalition, business, taxes
New taxes will help the budget not so much as they will hurt businesses
Tax initiatives of the coalition could drain the national budget
The coalition cannot distribute VR committees due to the appetites of Samopomich
In order to post comments, you must login.
Cancel Add comment
Design, style, and all the contents of website www.capital.uaare protected by copyright and law. Any use of site materials is allowed only while meeting the requirements of reprinting terms and with the reference to www.capital.ua.Only materials in public domain can be used and adding of link and/or direct hyperlink open for search engines to immediate material address on www.capital.ua. The link/hyperlink should be placed in the sub-title or in the first paragraph of the material. Font size of the link or hyperlink should not be less than the font size of the main text in the material. Any use of materials that are in closed access and are only available to registered users is allowed only with the prior written permission of the copyright owner. Reprinting, copying, reproducing, modifying or any other use of materials published with the note of the agreement of syndication with Financial Times Limited are strictly prohibited. Use of materials which refers to France-Presse, Reuters, Interfax-Ukraine, Ukrainian News, UNIAN agencies is strictly prohibited. Materials marked are published as advertisements.
All rights reserved. © 2012 — 2016


text:
anita dawes and jaye marie
Books & Bonsai
Anita's Books…
Jaye's Books…
About Jaye…
Bonsai..
#Blog Battle
#WednesdayWriters ~ Nine Lives by Jaye Marie ~ Chapter 25 #MysteryThriller #Serialisation
February 20, 2019 February 20, 2019 / jenanita01
Chapter Twenty-five
Michael Barratt was having trouble believing just how stupid he had been. After all this time, after all his searching, what had possessed him to come on so strong and ruin whatever slim chance he had with Kate. He might have known time and distance would not mellow her in the slightest, that she would be as stubborn as ever.
It was always the way he was with her, never thinking before he spoke, always rushing headlong into stupidity. And the worst of it was he couldn't think of a single way to improve matters between them. She was right to be angry after the way he had behaved. Again.
To this day, he still didn't know why he had run away the minute he knew about the baby. Enough time had passed for him to try and figure out what he had obviously thought was wrong, and he was no smarter now than he was then, as only an idiot would have risked his one chance by behaving so stupidly.
Why did he think time might have changed things? It had probably made it more of a mess if anything.
There was a moment when the Kate he knew so well had surfaced. Not for long though, she had pulled back into her shell in a flash, but not before he glimpsed how she felt about him.
That tiny spark, that glimpse of what could be, gave him hope. More hope than I deserve, he thought wryly. He thought he had lost Kate forever when she had suddenly vanished from his father's house all those years ago. He had the gall to ask him where she had gone, that's how desperate he was. His father must have sensed it too, for he was uncharacteristically civil towards him, although he didn't know where she had gone either.
The old boy had looked so lonely and sad, Michael almost felt sorry for him, but something kept the normal father and son relationship at bay, and he walked away without once looking back.
When he found out she had married Jack Holland he became badly depressed, feeling all hope was gone. He had hidden away believing there was no point in anything anymore. He couldn't remember how long that state of mind had lasted and it seemed like a long lonely time, where all he could think of was losing the one good thing he had ever found.
Gradually, he remembered starting to worry about Kate. Was she happy? Did this Jack Holland treat her right? This made Michael feel worse, for if this man was hurting her there was nothing he could do about any of it, as he didn't have a clue where she was.
Eventually, he managed to pull himself out of his depression and started to look for her. He had no other clue than the surname and this turned out to be no help at all. It was almost as though this Jack Holland didn't exist and the fact he obviously did, meant he must have changed his name and at that realisation, the alarm bells started clanging.
His job as an estate agent came in handy, as he could move around to different areas quite easily. It also gave him access to property records, although they turned out to be no help either. He started systematically travelling around the south of England, giving himself six months in each location to check out every living soul in the neighbourhood.
He thought he caught glimpses of Kate as he made his rounds, but it was never her. He found himself looking at children, wondering if one of them was his son.
Sometimes women would mistake his interest for something more, and no matter how attractive they were, or how accommodating, he always politely declined their offers. Kate had become an obsession, one he would live with in the absence of the real thing. The thought of what he had thrown away still cut deep like a knife.
The day she walked into the estate office in Guildford, his heart seemed to stop beating. It was all he could do to breathe and appear normal when he felt like shouting the place down with all the joy he felt at the sight of her. He never doubted it was she; it couldn't possibly be anyone else. The proud way she held herself, the uncontrollable hair still wild although now streaked with silver. The way she looked at him, daring him to speak to her.
She gave herself away with all the hesitations and awkward pauses, could it be she had missed him? Against all hope, he wondered if she could possibly still love him?
Their meeting was short-lived and Kate ran away from him again. She said she would come back the next day but he had no intention of waiting that long. He found her address easily enough when he realised she was probably using her maiden name and when he later turned up at her flat, flowers in hand, he knew his suspicions were right. She was nervous, trying desperately to keep him at arm's length, but the chemistry was still there. He could feel it crackling in the air like electricity between them…
#writing, blogging, books, excerpt, life as an author, serial, sharing interests
#Nine Lives, #writing, blogging, books, chapter, mystery/thriller
← Life is Messy
Unseen… #Poetry →
Jaye Marie
Anita Dawes
Follow anita dawes and jaye marie on WordPress.com
Come and see us on Facebook!
My Moment... #Poetry
#Friday Flowers...
#Writephoto ~ Keep #Poetry
The 2.40... #Poetry
Circle... #Poetry
A reblog-#Keepitalive #Whatdoyousee #Poetry By Anita
Hopping #whatdoyousee
What My Top 5 Focus Tasks Are
Viral Blues (The Hat #2) by C.S. Boyack #bookreview #superheroes #paranormal
Home About Six: Part Eleven on beetleypete
Laying Low on Penny Wilson Writes
Guest Post: Darlene Foster on beetleypete
Need Reviews? Try Goodreads Re… on Myths of the Mirror


text:
Articles publicats (Medicina)
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease.
027504.pdf (1.471Mb)
Arcidiacono, Maria V.
Rimondi, Erika
Maietti, Elisa
Melloni, Elisabetta
Tisato, Veronica
Gallo, Stefania
Valdivielso Revilla, José Manuel
Fernández i Giráldez, Elvira
Betriu i Bars, M. Àngels
Voltan, Rebecca
Zauli, Giorgio
Volpato, Stefano
Secchiero, Paola
citations in Web of Science
citations in Scopus
Background: Chronic kidney disease (CKD) patients experience a high risk of cardiovascular disease (CV); however, the factors involved in CV-related morbidity and mortality in these patients have not been fully defined. Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is a cytokine,
which exhibits pleiotropic activities on endothelial, vascular smooth muscle and inflammatory cells, with relevant effects on atheromatous plaque formation. On this basis, the present study aims to investigate the role of TRAIL in atheromatosis progression in CKD patients. Methods: Circulating TRAIL levels were measured in 378 CKD patients belonging to the Spanish National Observatory of Atherosclerosis in Nephrology (NEFRONA) study. All patients were free of previous CV events. Carotid and femoral B-mode ultrasound was performed to detect the presence of plaque at baseline and after 24 months of follow-up. Results: The lowest levels of TRAIL at baseline were significantly (p<0.05) associated with the appearance, after 24 months of follow-up, of at least two new atheromatous plaques in all territories and of one new plaque in the carotid artery, even after adjusting for CV risk factors. In addition, the patients with low levels of TRAIL at baseline were characterized by the presence of at least one hypoechoic plaque in the carotid artery. This association was significant (p<0.05) even after adjusting for CKD stage. Conclusions: Overall, the results of our study suggest TRAIL as an assertable independent prognostic biomarker for atheromatosis plaque formation in CKD patients. This observation further supports the potential role of TRAIL for the prevention/treatment of CV disease.
http://hdl.handle.net/10459.1/65138
Plos One, 2018, vol. 13, num. 9, p. e0203716
Articles publicats (IRBLleida) [615]
Articles publicats (Medicina) [280]
Except where otherwise noted, this item's license is described as cc-by (c) Arcidiacono, Maria V. et al., 2018


Welcome to our cottage by the ocean. Don't just imagine sitting on the deck with a chilled glass of wine while the sun goes down, experience it! Relax at the end of your day by dining al fresco. Fall asleep to the sound of the waves and the smell of the ocean.
Situated on Middle Point Cove, five minutes from world-famous Peggy's Cove, our one-level cottage includes a fully-equipped kitchen, laundry, bath with walk-in shower, Wi-Fi, and queen beds in each of two bedrooms (sheets and towels provided). A great location for a your stay.
I grew up in Indian Harbour, only a stone's throw from this cottage. It is a beautiful place, even in the worst of weather! Being near the ocean brings a sense of peace to my busy world. I hope it does the same for you.
The cottage originally belonged to my brother, who was a fisherman. He passed away in 2015 and bequeathed his home to me. In order to be able to keep it, my husband and I made the decision to renovate it completely (no more bachelor pad) and add it to the rental market. Eventually, we will sell our home and retire to this one, where we can enjoy all the natural surroundings!
There is ample parking just outside the front door.
There is free Wi-Fi and password provided on arrival.
There is ample seating with a sofa, and two swivel rocker chairs. Put your feet up and relax.
A few staple pantry items such as flour, sugar, and basic spices are included.
A 42-inch Smart TV is available, along with an Android box for movies and television viewing.
There are a few books available.
A few board games are available in the cottage.
Bicycle rental and trails are only a 20 minute drive away.
The cottage was in spotless condition and all appliances worked as expected. The only disappointment was the TV reception. The streaming services had major difficulties so viewing was spotty at best.
This place is just beautiful, it is very cosy and so welcoming. It is also stocked with everything you may need and even more.
We had a great three days here and I hope to be able to revisit one day.
My husband and I had a wonderful time at the Oceanside Cottage and highly recommend it when touring the south shore of Nova Scotia. The cottage was beautifully decorated and equipped with anything and everything you could imagine to cook a meal. The location on the water was lovely with fabulous sunsets. We were particularly impressed with how quickly the owner, Deborah Crooks responded to any questions we had before and during our stay.
The cottage was ideally located for trips to Peggy's Cove, Halifax, Lunenberg, Mahone Bay and lovely beaches from Hubbard to Queensland.
We didn't want to leave!!!
We had such a great time at Deborah's property which is right next to Peggy's cove! We stayed there for 4 nights but wished we could have stayed longer. The house is really lovely, very cosy and well equipped so as to make your stay wonderful. The view from the property is gorgeous (and the sunsets are just breathtaking), you're close to some great hiking on the rocks near by, you can buy some delicious lobster next door (thanks to Deborah for providing us with a lobster pot!). And Indian Harbour is at the crossroads of many sightseeings (Halifax and the Citadel, Lunenburg and the Bluenose, and Peggy's cove where you can visit Deborah's shop which is very nice). From the time you step into Deborah's cottage, you can feel that she has put all her heart in the decoration of the place. Deborah, thanks a lot for this amazing stay.
The Middle Point Cottage is perfect! The scenery is stunning with beautiful sunrises and sunsets each day. The cottage itself is warm and welcoming and has been tastefully decorated and is very well maintained. Deb and Rico are responsive to all communication and the cottage has so many thoughtful things that enhance your stay - a well-equipped kitchen with tea, coffee, soap, etc., the same for the bathroom, and the bedrooms and living room have everything you need to feel right at home. For your entertainment, there was excellent wifi, a smart TV, books, guidebooks and travel brochures, and even binoculars!
Although the attractions and activities listed are within approximately 15 minutes away, far more activities are available within an hour.


2014/09/12 plagwitz	Enter your password to view comments.
Here is an overview of learning materials (Creation service) related articles, per language, on this blog/CMS, including shortcut links that save you building the advanced-search URLS as described in the upper right corner here.
This platform needs a better search/sort/filter – Excel Web App to the rescue: Here tags and categories are sorted alphabetically, allowing for and-searches, while the Excel advanced filters enables more sophisticated or-Searches. No search can be better than the metadata inputted, to clean that up, authenticated users can click the edit- or (make shift) daylink.
The LangLabEmailer helps integrating the digital audio lab (still widely operating based on files and network shares) into the departmental language teaching and learning process by automatically forwarding (audio, text) assessments and assignments collected in the digital audio lab to teachers and students via campus mail (using MS-Exchange automation).
Easy on the Language Lab Manager who can "set up and forget": 1000s of assessment files will reach their originating students and teachers in near real time without you lifting a finger.
To earn "extra credit", show your teachers how they can override the default LangLabEmailer behavior by adding "_noemailing" or "_nostudentemailing" to the folder name when saving their digital audio lab collections.
Samples & questions at my IALLT 2013 session.


text:
Splendour In The Grass Concerts To Be Streamed Live
Splendour In The Grass will stream full sets from Blur, Royal Blood, Of Monsters and Men, Peking Duk and Jarryd James this year.
Los Lobos To Release 'Gates Of Gold', Their 20something Album
Los Lobos, the Grammy winning East L.A. legends comprised of David Hidalgo, Louie Perez, Cesar Rosas, Conrad Lozano and Steve Berlin, are back with an all new full length studio album, Gates of Gold, which will be released September 25 on 429 Records.
New Faces Box Set Coming In August
The Faces are about to be given a make-over with a new box set 'You Can Make Me Dance, Sing Or Anything' coming in August.
Rosanne Cash Inducted Into Nashville Songwriters Hall of Fame
The Nashville Songwriters Hall of Fame announced their class of 2015 on Thursday with the induction of Rosanne Cash, Craig Wiseman, Mark James and Even Stevens.
Rick Springfield's Niece Kaya Nicole Releases Debut 'Morning'
Kaya Nicole is about to release her debut album 'Morning'. Who you say?
Toby Keith Preps 36mph Town Album
Toby Keith will release his eighteenth studio album, 35 MPH Town, on October 9 via Show Dog Nashville.
The Who Release Classic 1982 Shea Stadium DVD
1982 was supposed to be it for The Who's touring career. They had made it clear that year that the tour to support their then new album, It's Hard, was going to be their last one. Of course, that was not to be the case, and the bands 1982 trek of North American really just turned out to be their final tour with drummer Kenny Jones.
Greatest Hits Take Over British Charts
The British are suddenly very interested in Greatest Hits sets from veteran artists.
Duran Duran's Simon Le Bon Says One Direction Is A Cash Cow
Simon Le Bon thinks One Direction is a cash cow for many people.
R.I.P. The Diamonds Dave Somerville 1933-2015
Dave Somerville, the original lead singer for the Canadian group the Diamonds, died from cancer in Santa Barbara, CA on Tuesday at the age of 81.
Black Crowes' Rich Robinson Goes Ed Sheeran-like Solo
Rich Robinson, the former guitarist, songwriter, and co-founder of The Black Crowes is going Ed Sheeran-like solo. It will be just Rich and guitars on stage.
Don Henley Reveals Details Of Cass County Solo Album
Don Henley has given fans a taste of his upcoming solo album 'Cass County'.
The Rolling Stones Wrap-Up Zipcode Tour In Quebec Plus Tour Song Stats
The Rolling Stones have wrapped by their tour duties for 2015 after 15 shows, one showcase and one private party in North America.
High School Reunion Brisbane Sells Out In Days
Brisbane's High School Reunion has sold out within days of going on sale.
Dave Grohl Is Up For An Emmy Award
Dave Grohl could earn himself an Emmy Award after Foo Fighters 'Sonic Highways' was nominated this week.
David Williams Launches David Roy Williams Music
Shock Records founder David Williams has launched his new music group David Roy Williams Music.
Wilco Have Just Released A New Album Star Wars And Its Free
Wilco have just released an 11 track album of brand new songs titled 'Star Wars' free for fans.
David Gilmour Reveals New Album Rattle That Lock
Former Pink Floyd member David Gilmour will release his new solo album, Rattle That Lock in September.
What If Your Streaming Services Were Real People? Check Out This Hilarious Pisstake
Spotify is going through a painful breakup with Apple Music coming along and offering something that it can't … Taylor Swift.
Bluesfest Announce Earliest Artist Announcement Ever And Here It Is
Bluesfest has just dropped its earliest announcement ever with 13 acts named for the 2016 event.
David Bowie, Angus Young Guest On Noise11 iHeartRadio
David Bowie and AC/DC's Angus Young speak this week for iHeartRadio Music News powered by Noise11.com.
Joe Jackson Has A New Record And He Sounds Like Joe Jackson Again
Joe Jackson will release Fast Forward on October 2 and has set a tour to accompany the new set.
Keith Richards Switches To Solo After Stone Tour, Listen To His New Song
The Rolling Stones 'Zipcode' tour is over and Keith Richards has immediately switched to solo mode with a brand new song for us all to hear.
New Music Releases For July 17 2015
Tame Impala, Chemical Brothers, Ms Mr, Pitbull (Latin), Art of Sleeping and the Ant-Man soundtrack lead the week's new releases.
R. Kelly Wants To Perform At Iggy Azalea Wedding
R. Kelly is 'open' to performing at Iggy Azalea's wedding.
Justin Bieber's Mother Found Scooter Braun Creepy
Justin Bieber's mother initially thought Scooter Braun was "creepy" because he was hounding her.
Simon & Garfunkel Come Full Circle Back To Vinyl
Legacy Recordings, the catalog division of Sony Music Entertainment, will commemorate five decades of Simon & Garfunkel's extraordinary sound with two special career-defining collections to be released in August.
Editors Reveal New Album and Tour Details
Editors have announced the forthcoming release of their fifth studio album, 'In Dream' by Play It Again Sam worldwide for October.
Bobby Brown Christens Baby Daughter
Bobby Brown has selected a Buddhist moniker for his infant daughter.
Neil Young Pulls Catalogue From Streaming Sites
Neil Young has joined Prince in pulling his music from all streaming services.